Mengfei Yao

1.3k total citations
25 papers, 904 citations indexed

About

Mengfei Yao is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Mengfei Yao has authored 25 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Mengfei Yao's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Mengfei Yao is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Mengfei Yao collaborates with scholars based in China, United States and Finland. Mengfei Yao's co-authors include Tianqi Wu, Jianhua Wang, Leilei Du, Xiaojie Bian, Ningning Ma, Haijing Liu, Shancheng Ren, Yu‐Tian Xiao, Yongqiang Huang and Yanan Cao and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Chemical Communications.

In The Last Decade

Mengfei Yao

23 papers receiving 901 citations

Peers

Countries citing papers authored by Mengfei Yao

Since Specialization

Citations

This map shows the geographic impact of Mengfei Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengfei Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengfei Yao more than expected).

Fields of papers citing papers by Mengfei Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengfei Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengfei Yao. The network helps show where Mengfei Yao may publish in the future.

Co-authorship network of co-authors of Mengfei Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Mengfei Yao. A scholar is included among the top collaborators of Mengfei Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengfei Yao. Mengfei Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TRIM21 promotes colorectal cancer development through regulating DNA replication by TCF3/MCM2/5 axis 2025 ·Cell Death Discovery ·Xintian Zhang, (unknown), Yichao Hou, (unknown), (unknown), Lidan Hou, Xingming Zhang, Wenfeng Wang, Leilei Du, Mengfei Yao, Jianhua Wang, Xiangjun Meng	0
2	Lon protease 1-mediated metabolic reprogramming promotes the progression of prostate cancer 2025 ·Cell Death and Disease ·Mengfei Yao, Xingming Zhang, Tianqi Wu, Feng Tao, Xiaojie Bian, Mierxiati Abudurexiti, Wenfeng Wang, Guo-Hai Shi, Gong‐Hong Wei, Qin Zhang, Xiangyun Li, Gang Feng, Leilei Du, Jianhua Wang	1
3	GABPA inhibits tumorigenesis in clear cell renal cell carcinoma by regulating ferroptosis through ACSL4 2024 ·Scientific Reports ·Yaqian Wu, (unknown), Mengfei Yao, Li Liu, Yimeng Song, Lulin Ma, Cheng Liu	4
4	Microscale Changes in Residual Oil under Low Salinity Water Flooding in Offshore Sandstone Reservoirs Using X-ray Technology 2024 ·Energy & Fuels ·Xiaochen Zhang, Lei Tang, (unknown), Mengfei Yao, (unknown), Xiaowen Liu, Yanjun Li, (unknown), Kai Wei, Wei Shi	0
5	Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression 2022 ·Cell Death and Disease ·Tianqi Wu, Wenfeng Wang, Guohai Shi, Mingang Hao, Yingying Wang, Mengfei Yao, Yongqiang Huang, Leilei Du, Xingming Zhang, Dingwei Ye, Xiaojie Bian, Jianhua Wang	38
6	Inhibition of N-Acetyltransferase 10 Suppresses the Progression of Prostate Cancer through Regulation of DNA Replication 2022 ·International Journal of Molecular Sciences ·Ningning Ma, Haijing Liu, (unknown), Mengfei Yao, Bo Zhang	25
7	LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer 2021 ·Cell Death and Disease ·Wenjie Luo, Jun Wang, Wenhao Xu, Chunguang Ma, Fangning Wan, Yongqiang Huang, Mengfei Yao, Hailiang Zhang, Yuanyuan Qu, Dingwei Ye, Yiping Zhu	131
8	Comprehensive analysis of alternative splicing profiling reveals novel events associated with prognosis and the infiltration of immune cells in prostate cancer 2021 ·Translational Andrology and Urology ·Tianqi Wu, Wenfeng Wang, (unknown), Mengfei Yao, Leilei Du, Xingming Zhang, Yongqiang Huang, Jianhua Wang, Hongbo Yu, Xiaojie Bian	4
9	Diethyldithiocarbamate-copper complex (CuET) inhibits colorectal cancer progression via miR-16-5p and 15b-5p/ALDH1A3/PKM2 axis-mediated aerobic glycolysis pathway 2021 ·Oncogenesis ·Xin Huang, Yichao Hou, Xiaoling Weng, Wenjing Pang, Lidan Hou, Yu Liang, Yu Wang, Leilei Du, Tianqi Wu, Mengfei Yao, Jianhua Wang, Xiangjun Meng	52
10	N-Acetyltransferase 10 Promotes Micronuclei Formation to Activate the Senescence-Associated Secretory Phenotype Machinery in Colorectal Cancer Cells 2020 ·Translational Oncology ·Yanan Cao, Mengfei Yao, (unknown), Ningning Ma, Haijing Liu, Bo Zhang	43
11	Remodelin, an inhibitor of NAT10, could suppress hypoxia-induced or constitutional expression of HIFs in cells 2020 ·Molecular and Cellular Biochemistry ·(unknown), Yanan Cao, Haijing Liu, Mengfei Yao, Ningning Ma, Bo Zhang	20
12	LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression 2020 ·Cell Death and Disease ·Mengfei Yao, Xiaolei Shi, Yue Li, Yu‐Tian Xiao, William Butler, Yongqiang Huang, Leilei Du, Tianqi Wu, Xiaojie Bian, Guohai Shi, Dingwei Ye, Guo‐Hui Fu, Jianhua Wang, Shancheng Ren	29
13	Dichloroacetate Overcomes Oxaliplatin Chemoresistance in Colorectal Cancer through the miR-543/PTEN/Akt/mTOR Pathway 2019 ·Journal of Cancer ·(unknown), Danxi Zhu, Li Zhu, Yichao Hou, Lidan Hou, Xin Huang, Linjing Li, Yu Wang, Lei Li, Huimin Zou, Tianqi Wu, Mengfei Yao, Jianhua Wang, Xiangjun Meng	42
14	Microvesicles and chemokines in tumor microenvironment: mediators of intercellular communications in tumor progression 2019 ·Molecular Cancer ·Xiaojie Bian, Yu‐Tian Xiao, Tianqi Wu, Mengfei Yao, Leilei Du, Shancheng Ren, Jianhua Wang	120
15	Loss of hypermethylated in cancer 1 (HIC1) promotes lung cancer progression 2018 ·Cellular Signalling ·Yue Li, Mengfei Yao, Tianqi Wu, Liyan Zhang, Yingying Wang, Liang Chen, Guo‐Hui Fu, Xiaoling Weng, Jianhua Wang	8
16	The nuclear GSK-3β regulated post-transcriptional processing of mRNA through phosphorylation of SC35 2018 ·Molecular and Cellular Biochemistry ·Yu An, Yongxin Zou, Yanan Cao, Mengfei Yao, Ningning Ma, (unknown), Jing Yang, Haijing Liu, Bo Zhang	5
17	HIC1 deletion promotes breast cancer progression by activating tumor cell/fibroblast crosstalk 2018 ·Journal of Clinical Investigation ·Yingying Wang, Xiaoling Weng, Luoyang Wang, Mingang Hao, (unknown), Lidan Hou, Yu Liang, Tianqi Wu, Mengfei Yao, Guowen Lin, Yiwei Jiang, Guo‐Hui Fu, Zhaoyuan Hou, Xiangjun Meng, Jinsong Lu, Jianhua Wang	63
18	The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy 2016 ·PLoS ONE ·Qingqing Cai, Kailin Chen, Jie Chen, Shaoxu Wu, Qirong Geng, Huiqiang Huang, Tongyu Lin, Wenqi Jiang, Zhongjun Xia, Huaxin Duan, Hui‐Lan Rao, Mengfei Yao, (unknown)	9
19	Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction 2016 ·Cell Death and Disease ·K. Y. Shan, Qin Jiang, (unknown), (unknown), Hong Yang, Mengfei Yao, Chongdong Liu, (unknown), Jin Yao, Bin Liu, Yangyang Zhang, (unknown), Biao Yan	188
20	Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels 2009 ·Mucosal Immunology ·Emily J. Ciccone, (unknown), Peter Mannon, Mengfei Yao, Jessica N. Hodge, Robin Dewar, Cheryl Chairez, Michael A. Proschan, Joseph A. Kovacs, Irini Sereti	63

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact